Women’s and Men’s Reproductive Health Pharma Company Besins Healthcare, has opened a new hormone production facility in Muel, Spain, bolsteing their global hormone production capacity by a 30%. This milestone is a response to the growing worldwide demand for hormones, particularly concerning late pregnancies and menopause. The opening follows Besins Healthcare’s strategic acquisition of a hormone production site in Drogenbos, Belgium, in…
Mira is a San Francisco-based company that provides healthcare products for more personal, accurate, and reliable home healthcare. Quanovate was founded in late 2015 by a group of scientists, engineers, OBGYN doctors, and business execs to solve the problem of the unavailability of advanced home health testing. The company’s mission is to make home healthcare more personalized and reliable, while empowering people…
Celmatix, a women’s health biotech company focused on ovarian biology, and Aché Laboratórios, a pharmaceutical company based in Brazil, have announced a collaboration to study a recently discovered melatonin receptor agonist. Their joint research aims to explore its potential applications in women’s health, with a primary focus on polycystic ovary syndrome (PCOS). This announcement follows Celmatix’s recent unveiling of its drug program,…
Reproductive and gynecological health has often been a subject surrounded by societal taboos, misconceptions, and general lack of awareness. Despite this, statistical data reveals that approximately one in three individuals will experience a reproductive or gynecological health issue at some stage in their lives. The need for reliable, accessible, and comprehensive healthcare solutions is evident and in my search for such a…
L’Oréal, the global beauty company, has unveiled new research and innovations in skin health at the prestigious World Congress of Dermatology (WCD) held in Singapore this month. The event gathered top dermatologists, scientists, and researchers to explore the latest advancements in the field. Vichy, a brand under L’Oréal Dermatological Beauty (LDB), presented a significant study investigating the effects of hormonal variations on…
May Health, a clinical-stage medical device company focusing on polycystic ovary syndrome (PCOS), presented promising results from the ULTRA-EU and ULTRA-US feasibility clinical trials for its Ovarian Rebalancing treatment at the 39th Annual European Society of Human Reproduction and Embryology (ESHRE) meeting. The trials demonstrated the treatment’s safety and effectiveness in inducing ovulation in women with PCOS-related infertility. The company also received…
A couple of weeks ago many of you joined us for our Inner Circle webinar on the topic of innovation in women’s hormone health. And I’m glad we finally managed to put got this webinar together, as hormone health is one of these areas of women’s health that’s more than ripe for disruption. One of the reasons it took us so long to…
Bonatra, a healthtech startup, has recently announced its acquisition of MyAva, a women’s health and wellness company. This move is aimed at expanding Bonatra’s holistic healthcare programs, and establishing it as a comprehensive platform for managing chronic health conditions. MyAva is a femtech startup that offers curated programs and personalized plans to help women manage chronic health conditions such as PCOS, thyroid…
